No reduced risk seen among older patients, those at risk for hospitalization
More patients taking alectinib with low-fat yogurt do not reach the exposure threshold of 435 ng/mL
Generally comparable proportion of infants with injection-site, systemic, vaccine-related, serious adverse events for V114 and PCV13